Literature DB >> 4110896

Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.

K Yamashita, J B Field.   

Abstract

Both thyroid-stimulating hormone (TSH) and long-acting thyroid stimulator (LATS) stimulated adenyl cyclase activity in plasma membranes obtained from bovine thyroid glands. The stimulation induced by LATS was much less than that obtained with maximal amounts of TSH. LATS inhibited TSH stimulation of adenyl cyclase activity while an equivalent amount of normal human gamma-globulin did not influence basal or TSH-stimulated activity. The inhibition by LATS appeared to be noncompetitive and was greatest when the plasma membranes were initially exposed to LATS for 30 min at 0 degrees C before being incubated with TSH for 10 min at 37 degrees C. Inhibition could still be demonstrated when the plasma membranes were incubated for 30 min at 0 degrees C with TSH before the addition of LATS. Prolonging the period of incubation of plasma membranes with LATS from 30 to 60 min did not augment the stimulation of adenyl cyclase or increase the inhibition of the effect of TSH. Papain digests of LATS also increased adenyl cyclase activity of thyroid plasma membrane and inhibited the stimulation induced by TSH. The inhibitory effect of LATS was not completely specific for TSH and thyroid plasma membranes since glucagon stimulation of adenyl cyclase in hepatic plasma membranes was also inhibited, but to a lesser extent. In contrast to the results obtained with thyroid plasma membranes, LATS did not influence basal adenyl cyclase activity in hepatic plasma membranes. Furthermore equivalent amounts of normal human gamma-globulin also decreased glucagon stimulation of adenyl cyclase activity in plasma membranes obtained from liver. The present data suggest that LATS stimulation of adenyl cyclase in thyroid plasma membranes might be due to a change in the membrane configuration rather than binding to a specific receptor site. Such modification of the membrane structure could interfere with the binding of TSH to specific receptors or to the subsequent stimulation of adenyl cyclase. However, the results do not exclude the possibility that some component in the preparation other than LATS might be responsible for the inhibition of the stimulation by TSH.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4110896      PMCID: PMC302151          DOI: 10.1172/JCI106834

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

Review 1.  REVIEW: PATHOGENESIS OF GRAVES' DISEASE: ROLE OF THE LONG-ACTING THYROID STIMULATOR.

Authors:  J M MCKENZIE
Journal:  J Clin Endocrinol Metab       Date:  1965-03       Impact factor: 5.958

2.  Recovery of the long-acting thyroid stimulator from serum of patients with thyrotoxicosis by concentration of immunoglobulin G.

Authors:  L Carneiro; K J Dorrington; D S Munro
Journal:  Clin Sci       Date:  1966-10       Impact factor: 6.124

3.  Factors influencing adenosine 3',5'-phosphate accumulation in bovine thyroid slices.

Authors:  A G Gilman; T W Rall
Journal:  J Biol Chem       Date:  1968-11-25       Impact factor: 5.157

4.  Activation of adenyl cyclase in thyroid homogenates by thyroid-stimulating hormone.

Authors:  I Pastan; R Katzen
Journal:  Biochem Biophys Res Commun       Date:  1967-12-29       Impact factor: 3.575

5.  On the competitive interaction of long-acting thyroid stimulator and thyrotropin in vivo.

Authors:  G Burke
Journal:  J Clin Endocrinol Metab       Date:  1968-02       Impact factor: 5.958

6.  Interaction of thyrotropin or the long-acting thyroid stimulator with theophylline.

Authors:  C H Bastomsky; J M McKenzie
Journal:  Endocrinology       Date:  1968-08       Impact factor: 4.736

7.  Stimulation of RNA and phospholipid formation by long acting thyroid stimulator and by thyroid-stimulating hormone.

Authors:  Y Ochi; L J DeGroot
Journal:  Biochim Biophys Acta       Date:  1968-11-12

8.  Comparison of early effects of thyrotropin and long-acting thyroid stimulator on thyroid secretion.

Authors:  Y Shishiba; D H Solomon; G N Beall
Journal:  Endocrinology       Date:  1967-05       Impact factor: 4.736

9.  Comparative effects of long-acting thyroid stimulator and pituitary thyrotropin on the intermediate metabolism of thyroid tissue in vitro.

Authors:  T W Scott; B F Good; K A Ferguson
Journal:  Endocrinology       Date:  1966-11       Impact factor: 4.736

10.  In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids.

Authors:  J B Field; A Remer; G Bloom; J P Kriss
Journal:  J Clin Invest       Date:  1968-07       Impact factor: 14.808

View more
  6 in total

1.  Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.

Authors:  C R Kahn; K Baird; J S Filier; D B Jarrett
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

Review 2.  Aetiology of hyperthyroidism. II.

Authors:  R Hoffenberg
Journal:  Br Med J       Date:  1974-08-24

3.  Biphasic effect of 5'-guanylylimidodiphosphate on fat cell adenylate cyclase.

Authors:  R Ebert; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  A radio-ligand receptor assay for the long-acting thyroid stimulator. Inhibition by the long-acting thyroid stimulator of the binding of radioiodinated thyroid-stimulating hormone to human thyroid membranes.

Authors:  S Q Mehdi; S S Nussey
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

5.  Detection of thyroid-stimulating antibodies in thyroid diseases, employing rat thyroid fragment perifusion.

Authors:  J R Attali; P Valensi; D Darnis; C Weisselberg; J Sebaoun
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

6.  Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man.

Authors:  J S Flier; C R Kahn; D B Jarrett; J Roth
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.